Pulmonology
News
Breakthrough infections twice as likely to be asymptomatic
New research found that of 1.2 million adults who received at least one dose of either the Pfizer, Moderna, or AstraZeneca vaccine, fewer than 0.5...
Clinical
Limited evidence for interventions to reduce post-op pulmonary complications
Do perioperative interventions reduce postoperative pulmonary complications (PPCs) in patients undergoing noncardiac surgery?
News
Two swings, two misses with colchicine, Vascepa in COVID-19
The study cohorts varied from healthcare and public workers at high risk for infection to individuals already hospitalized with COVID-19.
News
‘Deeper dive’ into opioid overdose deaths during COVID pandemic
Results also showed that, compared to 2019, significantly more men died from overdoses in 2020 in Colorado and Indiana.
Clinical
Early end for trial of experimental oxygenation strategies in ARDS
Does a conservative oxygenation strategy improve mortality in patients with acute respiratory distress syndrome (ARDS)?
News
Genetic link may tie cannabis use disorder to severe COVID-19
“These data have important implications for policy regarding vaccination as well as treatment prioritization,” said lead author Dr. Alexander S....
Clinical
CRP as a biomarker for community-acquired pneumonia
Can biomarkers such as C-reactive protine (CRP) or procalcitonin be used as tools in diagnosis of outpatient CAP (community-acquired pneumonia)?...
Clinical
Use of point-of-care ultrasound (POCUS) for heart failure
Hospitalist use of POCUS may include guiding procedures, aiding in diagnosis, and assessing effectiveness of treatment.
News
Injectable monoclonal antibodies prevent COVID-19 in trial
The cocktail of casirivimab and imdevimab reduced the relative risk of infection by 72% in patients at high risk of infection.
Opinion
COVID-19: Delta variant is raising the stakes
Doctors have a special responsibility to make the case for vaccination – especially now, said Dr. Robert T. London.